Fulcrum Therapeutics, Inc.
HealthcareNASDAQ:FULC · NASDAQ Global Market
-$0.10 today
Vol 1.34M · Avg 1.73M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-49.64%
Period High
$14.60
Period Low
$3.14
Latest
$3.45
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
RAPT Therapeutics, Inc.
RAPT
$959.26M
Lexicon Pharmaceuticals, Inc.
NASDAQ:LXRX
$852.86M
Omeros Corporation
NASDAQ:OMER
$632.20M
Neurogene Inc.
NASDAQ:NGNE
$459.84M
Ocugen, Inc.
NASDAQ:OCGN
$409.61M
Neumora Therapeutics, Inc. Common Stock
NASDAQ:NMRA
$329.81M
Lineage Cell Therapeutics, Inc.
AMEX:LCTX
$316.61M
Bicycle Therapeutics plc
NASDAQ:BCYC
$281.05M
Compass Therapeutics, Inc.
NASDAQ:CMPX
$280.72M
ADC Therapeutics S.A.
NYSE:ADCT
$133.55M
What is the latest FULC filing?
The latest filing shown is 8-K dated Jun 11, 2026.
How many recent filings does FULC have?
Intrinsic Alpha currently shows 20 recent filings for FULC.
Explore More
Continue the stock analysis
Jump to another research area for this company.